- KR₩70bn
- -KR₩131bn
- $21.98m
Brief: Access Bio Inc To Acquire 57 Billion Won Worth Of Shares And Majority Stake In Rfbio Co Ltd
Brief: Access Bio To Cancel 39 Billion Won Worth Of Own Shares
Brief: Access Bio Wins 118 Billion Won Order
Brief: Access Bio Inc Wins 61 Billion Won Order
Brief: Access Bio Inc Wins 61 Billion Won Order
Brief: Atomo Diagnostics Seeks Trading Halt
Australia's Atomo Diagnostics jumps 60% on FDA nod for COVID-19 test kit
Australia's Atomo Diagnostics jumps on plans to enter North America
Brief: Access Bio receives patent
Brief: Access Bio signs contract worth 3.45 bln won
Brief: Access Bio receives patent
Brief: Access Bio signs contract worth 5.82 bln won
Brief: Access Bio receives Philippines patent
Brief: Access Bio receives patent
Brief: Access Bio lowers conversion price of 2nd series convertible bonds to 4,834 won/share
Brief: GE, Global Good Licensing deal with Access Bio brings asymptomatic malaria rapid diagnostic tests to market
Brief: Access Bio receives patent
Brief: Access Bio signs contract worth 2.0 bln won
Brief: Access Bio lowers conversion price of 1st series bonds to 5,535 won/share